8-KShareholder Matters

COMCAST CORP 8-K Report, Shareholder Vote Results (Jun 1, 2012)

Filed June 1, 2012For Securities:CMCSACCZ

Summary

This 8-K filing from Comcast Corp. (CMCSA) details the outcomes of various proposals voted on at the company's annual shareholder meeting held on May 31, 2012. The primary focus for investors is the confirmation of all director nominees, the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2012, and the approval of two employee stock purchase plans. The results indicate strong shareholder support for the incumbent board and established governance practices. Notably, several shareholder proposals, including those for cumulative voting, an independent board chairman, and a share retention policy for executives, did not receive majority approval. Conversely, a shareholder proposal to make poison pills subject to a shareholder vote was approved, signifying a shift in sentiment on certain corporate governance matters. These outcomes provide insight into shareholder priorities and the board's responsiveness to them.

Key Highlights

  • 1All director nominees presented at the annual meeting were elected by shareholders to serve for one-year terms.
  • 2Deloitte & Touche LLP was ratified as the independent auditor for Comcast's fiscal year 2012.
  • 3The Comcast Corporation 2002 Employee Stock Purchase Plan, as amended and restated, received shareholder approval.
  • 4The Comcast-NBCUniversal 2011 Employee Stock Purchase Plan, as amended and restated, was also approved by shareholders.
  • 5Shareholder proposals for cumulative voting in director elections, an independent Chairman of the Board, and a senior executive share retention policy were not approved.
  • 6A shareholder proposal requiring poison pills to be subject to a shareholder vote was approved, indicating support for increased shareholder oversight on this matter.

Frequently Asked Questions

The key outcomes include the election of all director nominees, ratification of the independent auditor, and approval of two employee stock purchase plans. Several shareholder proposals regarding corporate governance reforms did not pass, but one concerning shareholder votes on poison pills was approved.

Shareholder proposals requesting cumulative voting for directors, an independent Chairman of the Board, and a share retention policy for senior executives did not receive majority approval.

The approval of the proposal to subject poison pills to a shareholder vote suggests that shareholders are seeking greater say and oversight on executive compensation and corporate defense mechanisms. This outcome might influence how Comcast structures its future corporate governance policies.

The appointment of Deloitte & Touche LLP as Comcast's independent auditors for the 2012 fiscal year was ratified with a significant majority of votes in favor (374,808,772 for vs. 2,694,358 against).